Allison Dorval - Net Worth and Insider Trading

Allison Dorval Net Worth

The estimated net worth of Allison Dorval is at least $4 Million dollars as of 2026-09-11. Allison Dorval is the CFO of Insulet Corp and owns about 22,342 shares of Insulet Corp (PODD) stock worth over $3 Million. Allison Dorval is the Director of Puma Biotechnology Inc and owns about 90,780 shares of Puma Biotechnology Inc (PBYI) stock worth over $833,179. Allison Dorval is also the CFO of Verve Therapeutics Inc and owns about 13,280 shares of Verve Therapeutics Inc (VERV) stock worth over $147,806. Besides these, Allison Dorval also holds Voyager Therapeutics Inc (VYGR) . Details can be seen in Allison Dorval's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Allison Dorval has not made any transactions after 2026-06-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Allison Dorval

Are these stocks worth buying? — GuruFocus analysis for each holding

- GF

PODD Insulet Corp

73% of holdings · $3.0M

PBYI Puma Biotechnology Inc

20% of holdings · $833K

VYGR Voyager Therapeutics Inc

4% of holdings · $146K

VERV Verve Therapeutics Inc

4% of holdings · $148K

Allison Dorval Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Allison Dorval owns 6 companies in total, including Voyager Therapeutics Inc (VYGR) , Insulet Corp (PODD) , and Puma Biotechnology Inc (PBYI) among others .

Click here to see the complete history of Allison Dorval’s form 4 insider trades.

Insider Ownership Summary of Allison Dorval

Ticker	Company	Transaction Date	Type of Owner
VYGR	Voyager Therapeutics Inc	2021-02-11	Vice President & Finance
PODD	Insulet Corp	2014-11-06	Chief Financial Officer
PBYI	Puma Biotechnology Inc	2026-06-12	director
		2021-07-15	director
		2025-04-02	Chief Financial Officer
		2021-07-15	director

Allison Dorval Latest Holdings Summary

Allison Dorval currently owns a total of 4 stocks. Among these stocks, Allison Dorval owns 22,342 shares of Insulet Corp (PODD) as of November 6, 2014, with a value of $3 Million and a weighting of 72.75%. Allison Dorval owns 90,780 shares of Puma Biotechnology Inc (PBYI) as of June 12, 2026, with a value of $833,179 and a weighting of 20.15%. Allison Dorval also owns 13,280 shares of Verve Therapeutics Inc (VERV) as of April 2, 2025, with a value of $147,806 and a weighting of 3.57%. The other 1 stocks Voyager Therapeutics Inc (VYGR) have a combined weighting of 3.53% among all his current holdings.

Latest Holdings of Allison Dorval

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
PODD	Insulet Corp	2014-11-06	22,342	134.64	3,008,127
PBYI	Puma Biotechnology Inc	2026-06-12	90,780	9.18	833,179
VERV	Verve Therapeutics Inc	2025-04-02	13,280	11.13	147,806
VYGR	Voyager Therapeutics Inc	2021-02-11	45,894	3.18	145,943

Holding Weightings of Allison Dorval

Allison Dorval Form 4 Trading Tracker

According to the SEC Form 4 filings, Allison Dorval has made a total of 0 transactions in Insulet Corp (PODD) over the past 5 years. The most-recent trade in Insulet Corp is the sale of 0 shares on November 6, 2014, which brought Allison Dorval around $0.

According to the SEC Form 4 filings, Allison Dorval has made a total of 4 transactions in Puma Biotechnology Inc (PBYI) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Puma Biotechnology Inc is the sale of 11,610 shares on June 12, 2026, which brought Allison Dorval around $83,592.

According to the SEC Form 4 filings, Allison Dorval has made a total of 4 transactions in Verve Therapeutics Inc (VERV) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Verve Therapeutics Inc is the sale of 3,350 shares on April 2, 2025, which brought Allison Dorval around $13,903.

More details on Allison Dorval's insider transactions can be found in the Insider Trading History of Allison Dorval table.

Insider Trading History of Allison Dorval

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Allison Dorval Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Get the full picture on these stocks

See GF Score, valuation, financials, and warning signs for every stock Allison Dorval owns.

- PODD - PBYI - VERV - VYGR

View PODD Analysis

Allison Dorval Ownership Network

Ownership Network List of Allison Dorval

No Data

Ownership Network Relation of Allison Dorval

Allison Dorval Owned Company Details

What does Voyager Therapeutics Inc do?

Who are the key executives at Voyager Therapeutics Inc?

Allison Dorval is the Vice President & Finance of Voyager Therapeutics Inc. Other key executives at Voyager Therapeutics Inc include Principal Accounting Officer Amy Quinlan , Chief Scientific Officer Todd Alfred Carter , and Chief Financial Officer Nathan D. Jorgensen .

Voyager Therapeutics Inc (VYGR) Insider Trades Summary

Over the past 18 months, Allison Dorval made no insider transaction in Voyager Therapeutics Inc (VYGR). Other recent insider transactions involving Voyager Therapeutics Inc (VYGR) include a net sale of 60,517 shares made by Alfred Sandrock , a net sale of 14,909 shares made by Robin Swartz , and a net sale of 11,000 shares made by Todd Alfred Carter .

In summary, during the past 3 months, insiders sold 0 shares of Voyager Therapeutics Inc (VYGR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 127,846 shares of Voyager Therapeutics Inc (VYGR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 127,846 shares.

Voyager Therapeutics Inc (VYGR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Voyager Therapeutics Inc Insider Transactions

No Available Data

What does Insulet Corp do?

Who are the key executives at Insulet Corp?

Allison Dorval is the Chief Financial Officer of Insulet Corp. Other key executives at Insulet Corp include director & President and CEO Ashley Mcevoy , EVP and CCO Michael Panos , and SVP & Global Operations Prem Singh .

Insulet Corp (PODD) Insider Trades Summary

Over the past 18 months, Allison Dorval made no insider transaction in Insulet Corp (PODD). Other recent insider transactions involving Insulet Corp (PODD) include a net sale of 4,357 shares made by Prem Singh , a net sale of 7,264 shares made by Eric Benjamin , and a net purchase of 5,400 shares made by Ashley Mcevoy .

In summary, during the past 3 months, insiders sold 0 shares of Insulet Corp (PODD) in total and bought 1,100 shares, with a net purchase of 1,100 shares. During the past 18 months, 28,806 shares of Insulet Corp (PODD) were sold and 14,632 shares were bought by its insiders, resulting in a net sale of 14,174 shares.

Insulet Corp (PODD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Insulet Corp Insider Transactions

No Available Data

What does Puma Biotechnology Inc do?

Who are the key executives at Puma Biotechnology Inc?

Allison Dorval is the director of Puma Biotechnology Inc. Other key executives at Puma Biotechnology Inc include Chief Financial Officer Maximo F Nougues , See Remarks Douglas M Hunt , and director & 10 percent owner & PRESIDENT & CEO & SECRETARY Alan H Auerbach .

Puma Biotechnology Inc (PBYI) Insider Trades Summary

Over the past 18 months, Allison Dorval made 2 insider transaction in Puma Biotechnology Inc (PBYI) with a net sale of 23,220. Other recent insider transactions involving Puma Biotechnology Inc (PBYI) include a net sale of 126,180 shares made by Alan H Auerbach , a net sale of 29,853 shares made by Maximo F Nougues , and a net sale of 25,264 shares made by Douglas M Hunt .

In summary, during the past 3 months, insiders sold 141,414 shares of Puma Biotechnology Inc (PBYI) in total and bought 0 shares, with a net sale of 141,414 shares. During the past 18 months, 399,467 shares of Puma Biotechnology Inc (PBYI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 399,467 shares.

Puma Biotechnology Inc (PBYI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Puma Biotechnology Inc Insider Transactions

No Available Data

What does Aerovate Therapeutics Inc do?

Who are the key executives at Aerovate Therapeutics Inc?

Allison Dorval is the director of Aerovate Therapeutics Inc. Other key executives at Aerovate Therapeutics Inc include director & 10 percent owner Ra Capital Healthcare Fund Lp , See Remarks George A Eldridge , and SENIOR VICE PRESIDENT & CMC Marinus Verwijs .

Aerovate Therapeutics Inc (AVTE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aerovate Therapeutics Inc (AVTE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerovate Therapeutics Inc (AVTE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aerovate Therapeutics Inc (AVTE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aerovate Therapeutics Inc Insider Transactions

No Available Data

What does Verve Therapeutics Inc do?

Who are the key executives at Verve Therapeutics Inc?

Allison Dorval is the Chief Financial Officer of Verve Therapeutics Inc. Other key executives at Verve Therapeutics Inc include director & 10 percent owner & Chief Executive Officer Sekar Kathiresan , Chief Administrative Officer Joan Nickerson , and See Remarks Andrew D. Ashe .

Verve Therapeutics Inc (VERV) Insider Trades Summary

Over the past 18 months, Allison Dorval made 1 insider transaction in Verve Therapeutics Inc (VERV) with a net sale of 3,350. Other recent insider transactions involving Verve Therapeutics Inc (VERV) include a net sale of 9,822 shares made by Sekar Kathiresan , a net sale of 3,235 shares made by Jason Politi , and a net sale of 2,777 shares made by Joan Nickerson .

In summary, during the past 3 months, insiders sold 0 shares of Verve Therapeutics Inc (VERV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 24,054 shares of Verve Therapeutics Inc (VERV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 24,054 shares.

Verve Therapeutics Inc (VERV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Verve Therapeutics Inc Insider Transactions

No Available Data

What does Jade Biosciences Inc do?

Who are the key executives at Jade Biosciences Inc?

Allison Dorval is the director of Jade Biosciences Inc. Other key executives at Jade Biosciences Inc include director & 10 percent owner Fairmount Healthcare Co-invest Iv L.p. , Chief Financial Officer Bradford D. Dahms , and director & 10 percent owner Fairmount Healthcare Fund Ii L.p. .

Jade Biosciences Inc (JBIO) Insider Trades Summary

Over the past 18 months, Allison Dorval made no insider transaction in Jade Biosciences Inc (JBIO). Other recent insider transactions involving Jade Biosciences Inc (JBIO) include a net purchase of 6,000 shares made by Tom Frohlich ,

In summary, during the past 3 months, insiders sold 0 shares of Jade Biosciences Inc (JBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Jade Biosciences Inc (JBIO) were sold and 6,000 shares were bought by its insiders, resulting in a net purchase of 6,000 shares.

Jade Biosciences Inc (JBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Jade Biosciences Inc Insider Transactions

No Available Data

Allison Dorval Mailing Address

Above is the net worth, insider trading, and ownership report for Allison Dorval. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Allison Dorval's mailing address is: Billerica Ma 01821.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.